Cost-effectiveness of technology-assisted buprenorphine for opioid use disorder: Analysis of three randomized trials.
Journal of substance use and addiction treatment · 2026
Abstract e pubblicazione originale
L’abstract è consultabile nella fonte originale. Non viene ripubblicato qui perché non risulta verificata una licenza compatibile.
Leggi nella fonte originale ↗Parole chiave
HumansBuprenorphineOpioid-Related DisordersCost-Benefit AnalysisCost-Effectiveness AnalysisRandomized Controlled Trials as TopicQuality-Adjusted Life YearsOpiate Substitution TreatmentNarcotic AntagonistsCost-effectivenessOpioid use disorder
Come citare questo studio
Kelly R Peck, Eric L Ross, Sydney R Batchelder, Donald S Shepard, Stacey C Sigmon. (2026). Cost-effectiveness of technology-assisted buprenorphine for opioid use disorder: Analysis of three randomized trials.. Journal of substance use and addiction treatment. DOI: 10.1016/j.josat.2026.210105
Consulta la pubblicazione originale ↗